|
|
|
30.10.25 - 23:18
|
XFRA: DIVIDEND/INTEREST INFORMATION - 03.11.2025 - US6294452064 (XETRA)
|
|
|
Das Instrument NVK US6294452064 NVE CORP. NEW DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 31.10.2025 und ex Dividende/Zinsen am 03.11.2025
The instrument NVK US6294452064 NVE CORP. NEW DL-,01 EQUITY has its pre-dividend/interest day on 31.10.2025 and its ex-dividend/interest day on 03.11.2025...
|
|
|
|
|
|
|
|
|
|
|
|
|
22.10.25 - 22:09
|
NVE Corporation Reports Second Quarter Results and Announces Quarterly Dividend (Business Wire)
|
|
|
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NVE Corporation (Nasdaq: NVEC) announced financial results today for the quarter ended September 30, 2025.
Total revenue for the second quarter of fiscal 2026 decreased 6% to $6.35 million from $6.76 million for the prior-year quarter. The decrease was due to a 68% decrease in contract research and development revenue, partially offset by a 1% increase in product sales. Net income for the second quarter of fiscal 2026 decreased 18% to $3.31 million, or $0.68 per diluted share, compared to $4.03 million, or $0.83 per share, for the prior-year quarter.
For the first six months of fiscal 2026, total revenue decreased 8% to $12.5 million from $13.5 million for the first six months of the prior year. The decrease was due to a 5% decrease in product sales and a 51% decrease in contract research and development revenue. Net income decreased 15% to $6.89 million, or $1.42 per diluted share, from $8.12 million, or $1.68 per share, for the first half of fiscal 2025.
The company...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.07.25 - 23:18
|
NVE Schedules Conference Call on First Quarter Results (Business Wire)
|
|
|
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter ended June 30, 2025 on Wednesday, July 23, 2025 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time.
The quarterly call will be webcast live in a listen-only mode through the Investor Events page of NVE's Website (www.nve.com). An archive of the call will also be available on NVE's Website.
To dial into the conference call, parties should call 855-552-4463 inside the United States, or 312-479-9427 and enter Meeting ID 7749 14 3539. Parties may request to ask questions on the call by dialing in or logging into https://chime.aws/7749143539.
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic produ...
|
|
|
|
|
15.05.25 - 23:54
|
XFRA: DIVIDEND/INTEREST INFORMATION - 19.05.2025 - US6294452064 (XETRA)
|
|
|
Das Instrument NVK US6294452064 NVE CORP. NEW DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 16.05.2025 und ex Dividende/Zinsen am 19.05.2025
The instrument NVK US6294452064 NVE CORP. NEW DL-,01 EQUITY has its pre-dividend/interest day on 16.05.2025 and its ex-dividend/interest day on 19.05.2025...
|
|
|
|
|
|
|
|
|
07.05.25 - 22:06
|
NVE Corporation Reports Fourth Quarter and Fiscal Year Results and Announces Quarterly Dividend (Business Wire)
|
|
|
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--$NVEC--NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and fiscal year ended March 31, 2025.
Total revenue for the fourth quarter of fiscal 2025 increased 3% to $7.27 million from $7.08 million for the prior-year quarter. The increase was due to a 558% increase in contract research and development revenue, partially offset by a 1% decrease in product sales. Net income for the fourth quarter of fiscal 2025 increased 2% to $3.89 million, or $0.80 per diluted share, compared to $3.81 million, or $0.79 per diluted share, for the prior-year quarter.
For fiscal 2025, total revenue decreased 13% to $25.9 million, compared to $29.8 million in the prior year. The decrease was due to a 16% decrease in product sales, partially offset by a 112% increase in contract research and development revenue. Net income for fiscal 2025 decreased 12% to $15.1 million, or $3.11 per diluted share, from $17.1 million, or $3.54 per share, for fiscal 2024.
The com...
|
|